BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37879498)

  • 1. BRD4-binding enhancer promotes CRC progression by interacting with YY1 to activate the Wnt pathway through upregulation of TCF7L2.
    Duan B; Zhou X; Zhang X; Qiu F; Zhang S; Chen Y; Yang J; Wang J; Tan W
    Biochem Pharmacol; 2023 Dec; 218():115877. PubMed ID: 37879498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway.
    Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX
    Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m
    Liu H; Li D; Sun L; Qin H; Fan A; Meng L; Graves-Deal R; Glass SE; Franklin JL; Liu Q; Wang J; Yeatman TJ; Guo H; Zong H; Jin S; Chen Z; Deng T; Fang Y; Li C; Karijolich J; Patton JG; Wang X; Nie Y; Fan D; Coffey RJ; Zhao X; Lu Y
    Mol Cancer; 2022 Mar; 21(1):74. PubMed ID: 35279145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of the nuclear Wnt pathway effector TCF7L2 promotes migration and invasion of human colorectal cancer cells.
    Wenzel J; Rose K; Haghighi EB; Lamprecht C; Rauen G; Freihen V; Kesselring R; Boerries M; Hecht A
    Oncogene; 2020 May; 39(19):3893-3909. PubMed ID: 32203164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.
    Konsavage WM; Kyler SL; Rennoll SA; Jin G; Yochum GS
    J Biol Chem; 2012 Apr; 287(15):11730-9. PubMed ID: 22337891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression.
    Mir R; Pradhan SJ; Patil P; Mulherkar R; Galande S
    Oncogene; 2016 Mar; 35(13):1679-91. PubMed ID: 26165840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRD4 Promotes Gastric Cancer Progression and Metastasis through Acetylation-Dependent Stabilization of Snail.
    Qin ZY; Wang T; Su S; Shen LT; Zhu GX; Liu Q; Zhang L; Liu KW; Zhang Y; Zhou ZH; Zhang XN; Wen LZ; Yao YL; Sun WJ; Guo Y; Liu KJ; Liu L; Wang XW; Wei YL; Wang J; Xiao HL; Liu P; Bian XW; Chen DF; Wang B
    Cancer Res; 2019 Oct; 79(19):4869-4881. PubMed ID: 31311807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors induce attenuation of Wnt signaling and TCF7L2 depletion in colorectal carcinoma cells.
    Götze S; Coersmeyer M; Müller O; Sievers S
    Int J Oncol; 2014 Oct; 45(4):1715-23. PubMed ID: 25050608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YY1-Induced Upregulation of Long Noncoding RNA ARAP1-AS1 Promotes Cell Migration and Invasion in Colorectal Cancer Through the Wnt/β-Catenin Signaling Pathway.
    Ye Y; Gu B; Wang Y; Shen S; Huang W
    Cancer Biother Radiopharm; 2019 Oct; 34(8):519-528. PubMed ID: 31173500
    [No Abstract]   [Full Text] [Related]  

  • 10. Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma.
    Sengupta D; Kannan A; Kern M; Moreno MA; Vural E; Stack B; Suen JY; Tackett AJ; Gao L
    Epigenetics; 2015; 10(6):460-6. PubMed ID: 25941994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-22-3p targeted regulating transcription factor 7-like 2 (TCF7L2) constrains the Wnt/β-catenin pathway and malignant behavior in osteosarcoma.
    Xue Y; Guo Y; Liu N; Meng X
    Bioengineered; 2022 Apr; 13(4):9135-9147. PubMed ID: 34753394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRD4 promotes glioma cell stemness via enhancing miR-142-5p-mediated activation of Wnt/β-catenin signaling.
    Wang J; Quan Y; Lv J; Gong S; Dong D
    Environ Toxicol; 2020 Mar; 35(3):368-376. PubMed ID: 31724259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Targeting of
    Huang M; Zeki J; Sumarsono N; Coles GL; Taylor JS; Danzer E; Bruzoni M; Hazard FK; Lacayo NJ; Sakamoto KM; Dunn JCY; Spunt SL; Chiu B
    Cancer Res; 2020 Mar; 80(5):1024-1035. PubMed ID: 31900258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant epigenetic regulation of bromodomain BRD4 in human colon cancer.
    Rodriguez RM; Huidobro C; Urdinguio RG; Mangas C; Soldevilla B; Domínguez G; Bonilla F; Fernandez AF; Fraga MF
    J Mol Med (Berl); 2012 May; 90(5):587-95. PubMed ID: 22120039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFL6 promotes cell proliferation in colorectal cancer via regulation of the WNT/β-catenin pathway.
    Zhang QW; Zhang XT; Tang CT; Lin XL; Ge ZZ; Li XB
    Mol Carcinog; 2019 Jun; 58(6):967-979. PubMed ID: 30693973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRD4 promotes gastric cancer progression through the transcriptional and epigenetic regulation of c-MYC.
    Ba M; Long H; Yan Z; Wang S; Wu Y; Tu Y; Gong Y; Cui S
    J Cell Biochem; 2018 Jan; 119(1):973-982. PubMed ID: 28681984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription Factor 7-like 2 Mediates Canonical Wnt/β-Catenin Signaling and c-Myc Upregulation in Heart Failure.
    Hou N; Ye B; Li X; Margulies KB; Xu H; Wang X; Li F
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27301468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin-specific protease 28 deubiquitinates TCF7L2 to govern the action of the Wnt signaling pathway in hepatic carcinoma.
    Sun X; Cai M; Wu L; Zhen X; Chen Y; Peng J; Han S; Zhang P
    Cancer Sci; 2022 Oct; 113(10):3463-3475. PubMed ID: 35880246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic regulation of asymmetric cell division by the LIBR-BRD4 axis.
    Chen HF; Chang CT; Hsu KW; Peng PH; Lai JC; Hung MC; Wu KJ
    Nucleic Acids Res; 2024 Jan; 52(1):154-165. PubMed ID: 37986225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the BRD4-HOXB13 Coregulated Transcriptional Networks with Bromodomain-Kinase Inhibitors to Suppress Metastatic Castration-Resistant Prostate Cancer.
    Nerlakanti N; Yao J; Nguyen DT; Patel AK; Eroshkin AM; Lawrence HR; Ayaz M; Kuenzi BM; Agarwal N; Chen Y; Gunawan S; Karim RM; Berndt N; Puskas J; Magliocco AM; Coppola D; Dhillon J; Zhang J; Shymalagovindarajan S; Rix U; Kim Y; Perera R; Lawrence NJ; Schonbrunn E; Mahajan K
    Mol Cancer Ther; 2018 Dec; 17(12):2796-2810. PubMed ID: 30242092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.